Regeneron Pharmaceuticals Inc. buy Truist Financial Co.
Start price
18.12.23
/
50%
€779.00
Target price
18.12.24
€957.22
Performance (%)
-11.96%
End price
19.12.24
€685.80
Summary
This prediction ended on 19.12.24 with a price of €685.80. The price of Regeneron Pharmaceuticals Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -11.96%. Truist_Financial_Co_ has a follow-up prediction for Regeneron Pharmaceuticals Inc. where he still thinks Regeneron Pharmaceuticals Inc. is a Buy. Truist_Financial_Co_ has 50% into this predictionRegeneron Pharmaceuticals, Inc. is a biotechnology company that is engaged in the discovery, development, and commercialization of medicines for the treatment of serious medical conditions. The company's products include EYLEA, a treatment for wet age-related macular degeneration and diabetic macular edema; Dupixent, a treatment for atopic dermatitis and asthma; and Libtayo, a treatment for certain types of cancer. Regeneron also has a strong focus on research and development, with a pipeline of potential new treatments for a variety of diseases. The company is headquartered in Tarrytown, New York and trades on the NASDAQ stock exchange under the symbol REGN.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Regeneron Pharmaceuticals Inc. | 0.777% | 0.777% | -54.469% |
| iShares Core DAX® | 1.043% | -0.149% | 34.887% |
| iShares Nasdaq 100 | 1.920% | 4.604% | 18.366% |
| iShares Nikkei 225® | 4.840% | 8.328% | 10.637% |
| iShares S&P 500 | 1.567% | 3.310% | 13.043% |
Comments by Truist_Financial_Co_ for this prediction
In the thread Regeneron Pharmaceuticals Inc. diskutieren
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $1,045.00 price target on the stock.
Ratings data for REGN provided by MarketBeat
In the thread Trading Regeneron Pharmaceuticals Inc.
Die von Truist_Financial_Co_ gewählte maximale Laufzeit wurde überschritten
Current prediction by Truist_Financial_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€936.00
24.09.24
24.09.24
€1,075.4
24.09.25
24.09.25
-48.55%
13.08.25
13.08.25
Stopped prediction by Truist_Financial_Co_ for Regeneron Pharmaceuticals Inc.
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€476.00
11.08.25
11.08.25
€696.13
11.08.26
11.08.26
0.82%
13.08.25
13.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€521.80
30.04.25
30.04.25
€826.73
30.04.26
30.04.26
-7.86%
13.08.25
13.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€522.60
23.04.25
23.04.25
€854.39
23.04.26
23.04.26
-8.00%
13.08.25
13.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€708.00
08.01.25
08.01.25
€973.98
08.01.26
08.01.26
-31.97%
13.08.25
13.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€782.60
01.11.24
01.11.24
€1,037.2
01.11.25
01.11.25
-38.46%
13.08.25
13.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€933.00
16.10.24
16.10.24
€1,045.5
16.10.25
16.10.25
-48.38%
13.08.25
13.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€1,017.0
02.08.24
02.08.24
€1,101.5
02.08.25
02.08.25
-52.59%
03.08.25
03.08.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€885.20
03.04.24
03.04.24
€1,049.8
03.04.25
03.04.25
-38.43%
04.04.25
04.04.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€892.50
26.03.24
26.03.24
€1,046.4
26.03.25
26.03.25
-33.89%
27.03.25
27.03.25
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€729.00
28.11.23
28.11.23
€951.37
28.11.24
28.11.24
-2.41%
29.11.24
29.11.24
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€734.00
16.08.23
16.08.23
€959.41
16.08.24
16.08.24
46.12%
17.08.24
17.08.24